Crawford Lake Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Crawford Lake Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-145,745	Closed	-$11.3M	–	99
2020 Q3	$11.3M	Buy	+145,745	New	+$10M	4.69%	5
2019 Q2	–	Sell	-15,562	Closed	-$411K	–	71
2019 Q1	$411K	Buy	+15,562	New	+$369K	0.13%	41

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Crawford Lake Capital Management's HZNP Position: Q4 2020 in Review

Crawford Lake Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2020, closing a stake of 145,745 shares — an estimated $11.3M sold.

Crawford Lake Capital Management first reported a position in HZNP in Q1 2019 and held it in 2 quarters. The position peaked at $11.3M in Q3 2020. 497 funds tracked by Wall St. Rank hold HZNP as of Q4 2020.

Crawford Lake Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2020 after selling out during the quarter.
Crawford Lake Capital Management sold 145,745 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2020, an estimated $11.3M.
Crawford Lake Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 2 quarters.
Crawford Lake Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $11.3M in Q3 2020.
497 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2020.

Based on Crawford Lake Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.